- Open Access
Exploring physiotherapists’ clinical definition and diagnosis of inflammatory conditions of the lactating breast in Australia: a mixed methods study
International Breastfeeding Journal volume 15, Article number: 48 (2020)
Differences in physiotherapy intervention practices for mastitis have been shown across Australian regions and facilities and it is unknown if this is associated with physiotherapists’ definition and diagnosis of Inflammatory Conditions of the Lactating Breast (ICLB). The aims were to determine how Australian physiotherapists’ define and diagnose ICLB and if there are regional or facility differences in their ICLB definition and diagnosis.
A cross-sectional mixed methods design was used to investigate how physiotherapists construct a definition and diagnosis of ICLB, via online qualitative and quantitative questions. Participants included 63 Australian physiotherapists who treated at least one woman with ICLB per month, over the last year. Thematic analysis and descriptive statistics were used to analyse qualitative and quantitative responses, respectively.
ICLB definition varied among physiotherapists (n = 63) with generated themes including definitions based on pathophysiology (57%), combination of local and systemic symptoms (38%), conditions (32%), local symptoms (25%) and breast function (16%). Overall, quantitative data supported these findings, as some physiotherapists considered blocked ducts an ICLB (83%), but some did not (17%), and some considered abscess and engorgement an ICLB (65%) and some did not (35%). For ICLB diagnosis, the main theme generated was lack of consensus between physiotherapists (n = 39) on the number or combination of local or systemic symptoms required. Quantitative data confirmed these themes, as 63% of physiotherapists (n = 63) indicated that more than one symptom was necessary to clinically diagnose ICLB, but 27% required only one symptom. For region and type of facility, consistency across the themes for region and facility was evident. Overall, quantitative data confirmed these findings, with no regional or facility differences, except physiotherapists from the Australian state of Victoria (96%) were more likely to consider blocked ducts as an ICLB, compared to those from the states of NSW (71%) or WA (71%) (n = 58; χ2 = 6.49, p = 0.04).
Australian physiotherapists have varied definitions of ICLB and the required ICLB symptoms for clinical diagnosis. These results may prompt physiotherapists, who treat ICLB, to engage in explicit communication when discussing an ICLB in patient care, when delivering information in training courses and in developing treatment guidelines.
The definition of mastitis adopted by the Academy of Breastfeeding Medicine (ABM) is breast inflammation presenting with “a tender, hot, swollen, wedge-shaped area of breast associated with temperature of 38.5°C or greater, chills, flu-like aching, and systemic illness” (p.239), and is consistent with other definitions [2, 3]. Mastitis affects up to 20% of lactating women worldwide [4,5,6,7,8,9,10,11] with the highest incidence occuring in the first 6 months postpartum . Untreated, mastitis can substantially impact on the mother’s health and daily functioning, potentially leading to the cessation of breastfeeding [1, 5]. Studies have shown that early cessation of breastfeeding reduces the known health benefits of lactation and breastfeeding to both mother and infant [13,14,15,16]. Thus it is important to support maintenance of breastfeeding and address potential barriers to continued breastfeeding, such as mastitis.
Mastitis is a narrow term meaning ‘breast inflammation’, from the latin ‘mastos’ (breast) and ‘itis’(inflammation) [17, 18]. However lactating breast conditions, such as breast abscess, blocked ducts or engorgement also present with clinical features of inflammation [19, 20], but may not be classified by physiotherapists as inflammatory. It can be difficult to differentiate between these inflammatory conditions based on clinical features alone [19, 20]. The ability of physiotherapists to consistently define and diagnose these inflammatory conditions may be problematic as there is little evidence to support the different diagnoses or to determine if these inflammatory conditions all have a similar causal pathway and natural history. As part of a healthcare team, physiotherapists provide care for women with lactating breast conditions, which may include therapeutic ultrasound, gentle massage, advice and education .
Contrastingly, Inflammatory Conditions of the Lactating Breast (ICLB) is an umbrella term that encompasses all inflammatory breast conditions. It is becoming more commonly used amongst physiotherapists since the introduction of a similar term in 2006  and the use of the term in the only training course in lactation endorsed by the Australian Physiotherapy Association (APA). Utilising a term that highlights the concept of inflammation for these conditions may enhance patient care as physiotherapists currently use inflammatory symptoms to guide diagnosis and interventions. It is unknown whether this overarching diagnostic label is clinically appropriate. It is also unclear if physiotherapists would consider ICLB a suitable umbrella term for lactating breast conditions.
An audit of mastitis intervention practices demonstrated differences across Australian regions and facilities . It was suspected that these differences might be related to how physiotherapists in different regions and facilities define and diagnose ICLBs. This would have implications for the transfer of care for patients between physiotherapists, regions and facilities and the development of national treatment guidelines. Therefore, the aims of this study were to determine how physiotherapists clinically define and diagnose ICLB and to determine if there are regional or facility differences in physiotherapists’ clinical ICLB definition and diagnosis.
This was a cross-sectional mixed methods study exploring how Australian physiotherapists construct their clinical definition and diagnosis of ICLB. Quantitative and qualitative data was obtained via secure online questionnaire that asked both closed (pick list) and open-ended questions (Qualtrics, Provo, UT, USA). Demographic data was collected via nine closed-ended quantitative questions, followed by another three closed-ended and two open-ended qualitative questions that investigated ICLB definition and diagnosis (Table 1). Physiotherapists were asked which symptoms or combination of symptoms lead them to diagnose specific breast conditions that could potentially be considered an ICLB. Physiotherapists were also required to identify which conditions they considered an ICLB. This was the first set of questions from a larger questionnaire exploring physiotherapists’ rationale for choice of interventions for ICLB. The results are reported using the Standards for Reporting Qualitative Research .
A pilot study that included five eligible physiotherapists, representing the major Australian population regions, was conducted from mid-July to early-August 2018, to ensure the questions were clearly understood, captured the required information and could be completed within 30–40 min. The pilot physiotherapists were colleagues of the researchers (EH, TM, NT, LM, AM) chosen based on their clinical experience treating ICLB. Alterations to the questions were based on email feedback from the pilot physiotherapists.
Participants were physiotherapists who treated women with ICLB. Eligibility was determined through online screening via the questionnaire link. Three closed questions preceding the questionnaire confirmed physiotherapists met the inclusion criteria: an Australian registered and practicing physiotherapist, treating women with ICLB, with an average frequency of at least monthly over the past 12 months. Physiotherapists were recruited across all eight regions (states and territories), representing private practices and public (hospital) facilities.
A systematic approach for recruitment was used to obtain a representative sample of physiotherapists, as no database of Australian physiotherapists who treat ICLB exists. Each region was mapped to identify all facilities that would employ Australian women’s health physiotherapists (those who offer women’s health services). Mapping was achieved through cross referencing Department of Health and Continence Foundation of Australia websites, regional women’s health directories, the APA “Find a Physio” database and online searching for advertisements of women’s health physiotherapy services. Contact emails were sourced online or through direct telephone contact with the facility. Recruitment posters were placed on the national women’s health physiotherapy Facebook page, LinkedIn accounts and women’s health physiotherapy postgraduate university online forums. The APA was contacted to distribute the electronic link to members of the women’s, men’s and pelvic health special interest groups. Snowball recruitment was also utilised.
This study was conducted between mid-August and mid-November 2018. To maintain anonymity, all personal data was de-identified prior to analysis and only postcode information; a four-digit number that provides geographical representation of Australian regions, was used to indicate the geographical location of participants.
Information power for the qualitative component of this study was achieved through the establishment of specific aims, inclusion of physiotherapists with specialised knowledge, and clearly stated online quantitative and qualitative questions . Information power was considered to be the amount of information obtained from women’s health physiotherapists that generated conceptually relevant themes . Data provided by physiotherapists were continuously assessed to determine whether sufficient information was obtained to achieve saturation, but recruitment was stopped at the end of the advertised period.
Data was exported into Microsoft Excel, then cleaned and checked for improbable answers and outliers (LM, BO). Quantitative data was used to verify and enhance the credibility of qualitative information via methodological triangulation . Thus, the results from the quantitative data and the qualitative data were compared to determine if they generated similar information. Descriptive statistics, such as means, counts and percentage of responses, were generated for quantitative data, and counts and percentages were generated for qualitative data to estimate the frequency of each theme. To determine regional and facility differences, chi square, Fisher’s exact test or McNemar’s test was used, as appropriate.
NVivo 11 Software (QSR International, Melbourne, Australia) was used to organise the qualitative data to allow for a rigorous qualitative thematic analysis approach [27, 28]. Deductive thematic analysis was optimal for investigating physiotherapists’ clinical definition and diagnostic criteria of ICLB as it enabled the generation of a set of themes that best reflected the content of the data in light of the research aims, while inductive thematic analysis was also used to derive themes from the raw data that were not determined a priori. Thematic analysis involved six phases: data familiarisation, code generation, theme generation, theme revision, theme definition, and result reporting . Three trained investigators (EH, BO, LM) independently conducted the analysis to improve the credibility of codes and themes. All coders were physiotherapists with experience in women’s health physiotherapy and women’s health physiotherapy research.
All coders read the written responses several times and labelled keywords with codes and grouped them into associated themes. Cross-coding was employed to develop a coding tree (Additional file 1) that was applied to all responses. Recurring themes were compared and discussed between coders to refine the main themes. The data was additionally inspected for differences and similarities of responses across regions and facilities (EH, BO, LM). Findings were further scrutinised by the extended research team to challenge and refine interpretations, ensuring robustness of the analysis.
Flow of participants through the study
A total of 537 valid email addresses of physiotherapists who could potentially meet eligibility criteria, were sourced from systematic nationwide recruitment strategies, and were sent the online link. Two reminder emails and one repeat social media post containing the online link were performed to maximise response rates, resulting in a total of 81 eligible physiotherapy participants (Fig. 1) .
Due to a small number of responses in some regions, only comparisons between NSW, Victoria and WA were analysed. Additionally, the small number of responses from some types of facilities (e.g. public health clinic) meant that only comparisons between private practices and hospital settings (either private or public) were conducted.
Most physiotherapists were located in Victoria, WA and NSW, had post-graduate qualifications, worked in private practice and had more than 2 years’ experience treating women with an ICLB (Table 2).
Physiotherapists’ definition of ICLB
Physiotherapists (n = 63) provided a variety of definitions for ICLB. The themes and supporting quotes are summarised in Table 3. The main subthemes identified included local breast clinical symptoms, combination of local and systemic clinical symptoms, pathophysiology/cause, discrete breast conditions, and altered breast function (Additional file 2).
Theme 1: The clinical definition of ICLB varies among physiotherapists.
Subtheme 1.1: The definition of ICLB was based on the presence of local and systemic clinical symptoms.
Many physiotherapists (n = 24, 38%) defined ICLB by the presence of a combination of local and systemic clinical symptoms: “the breast is hot, red and tender and the woman often feels extremely unwell” (P2). This was contrasted by 16 physiotherapists (25%) who based their definition on the presence of local clinical symptoms only: “any condition causing signs of inflammation such as redness, pain, swelling, heat” (P57).
Subtheme 1.2: The definition of ICLB was based on pathophysiology/cause.
Thirty-six physiotherapists (57%) stated there was a pathophysiology associated with the definition of ICLB. Many physiotherapists (n = 29, 46%) defined ICLB as an inflammatory process/response in the breast tissue with 14 physiotherapists (22%) stating it could have an infective or bacterial component/cause: “either bacterial or non-bacterial cause of inflammation within breast tissue” (P4). A total of 14 physiotherapists (22%) also included a physical or physiological cause of ICLB in their definition: “most commonly caused by a change in routine with feeding or difficulties with emptying the breast with feeding because of issues with the baby latching, nipple issues or feeding positions” (P81); “protein in milk crosses the duct wall into the surrounding tissue and sets up a local inflammatory response” (P20).
Subtheme 1.3: The definition of ICLB was constructed around discrete breast conditions.
In contrast, some physiotherapists (n = 20, 32%) listed discrete breast conditions: “engorgement, blocked ducts, mastitis” (P106) to define ICLB, with a few (n = 3, 5%) specifying it as a continuum of conditions, from “.. . milk stasis – inflammation – blocked duct – mastitis. ..” with potential for “… serious progression to abscess and sepsis” (P66).
Subtheme 1.4: The definition of ICLB comprised of altered breast function.
An additional 10 physiotherapists (16%) also included a disruption to feeding or breast function when defining ICLB: “inflammation of the breast tissue during lactation … most commonly associated with reduced function of the breast” (P49).
Quantitative data corroborated the themes of variability in definitions given for ICLB. Except for mastitis, physiotherapists did not unanimously agree on what conditions would be considered an ICLB (Table 4). For example, only 65% of physiotherapists considered abscess and engorgement an ICLB.
Physiotherapists’ diagnosis of ICLB
Physiotherapists (n = 39) provided a variety of combinations of clinical symptoms important for the diagnosis of ICLB. The themes and supporting quotes are summarised in Table 3. The main subthemes identified included local clinical symptoms and local and systemic clinical symptoms (Table 3). For these subthemes, generated themes included type and number of symptoms (Additional file 2).
Theme 2: The diagnosis of ICLB is based on the patient’s presenting symptoms but there is no consensus on the specific number or combination of local symptoms required, or if it includes systemic symptoms.
Subtheme 2.1: The diagnosis of ICLB is based on the presence of local clinical symptoms only.
Several physiotherapists (n = 22, 56%) believed a combination of local breast clinical symptoms (e.g. local pain/tenderness, tension/lump, erythema/redness, increased skin temperature/hot) to be important in diagnosing ICLB: “pain, erythema, tension, increased skin temperature” (P4).
Subtheme 2.2: The diagnosis of ICLB is based on the presence of local symptoms which is often associated with systemic clinical symptoms.
In contrast, 10 physiotherapists (26%) considered a combination of local symptoms plus the presence of systemic symptoms to be important in diagnosing ICLB “Change to local breast tissue such as lump/swelling, colour change and pain which may also be associated with systemic change such as fever/chills/temp” (P21).
Quantitative data corroborated the theme of inconsistency in the type of symptoms required to diagnose an ICLB. Although all physiotherapists believed that mastitis presents with both local inflammatory and systemic symptoms, there was less consistency in whether both local and systemic symptoms were required to diagnose the other ICLB conditions (Table 5).
Qualitative responses from physiotherapists indicated that a variety of symptoms were needed to diagnose ICLB, and the most frequently listed were swelling/tension/lump (n = 27, 69%), followed by pain/tenderness (n = 24, 62%) and redness (n = 23, 59%). For number of symptoms, a proportion of physiotherapists (n = 14, 36%) thought that three local symptoms were needed to diagnose ICLB: “at least 3 symptoms i.e. Pain, swelling and redness or increased temperature” (P94), closely followed by two local symptoms (n = 13, 33%): “unilateral pain and swelling are the main 2 symptoms I look for” (P20).
Quantitative data corroborated the theme of inconsistency in the specific number of symptoms required to diagnose ICLB. Almost two thirds of physiotherapists indicated that more than one symptom was necessary to make a clinical diagnosis of ICLB (Table 4). Most of the remaining physiotherapists required the presence of only one symptom (Table 4).
Regional and facility differences
There was consistency in the variety of qualitative themes identified across regions. Quantitative data only revealed a significant difference (N = 58, χ2 = 6.49, p = 0.04) between physiotherapists from different regions for whether or not blocked ducts were considered an ICLB. Physiotherapists from Victoria (n = 26; 96%) were more likely to consider that blocked ducts are an ICLB, compared to NSW (n = 10; 71%) or WA (n = 12; 71%). No other differences between regions existed for the remaining quantitative data.
Consistency was also observed in the qualitative themes regardless of the facility in which the physiotherapist works. No differences were found between hospital and private practice physiotherapists for the quantitative findings.
Overall, qualitative results emphasised variance amongst physiotherapists’ clinical definition of ICLB and symptoms required for diagnosis. Quantitative results indicated that abscess, blocked ducts, engorgement and mastitis were the main conditions physiotherapists considered an ICLB. All physiotherapists considered mastitis an ICLB, but not all physiotherapists considered other breast conditions to be an ICLB. Overall, there was no difference between regions or facilities in physiotherapists’ definition and diagnosis of ICLB.
Variability amongst physiotherapists for the clinical ICLB definition could indicate that the ICLB term is not well recognised. Variations in the mother’s presenting symptoms may impact on how a physiotherapist defines ICLB. When considering how physiotherapists may theoretically construct ICLB and mastitis, only 38% defined ICLB in a similar manner to previous definitions of mastitis [1,2,3], by including themes of local and systemic signs and symptoms. Physiotherapists defined ICLB with broader constructs (Table 4), indicating that ICLB could be considered a wider umbrella term than mastitis alone. In addition, 100% of physiotherapists defined mastitis as an ICLB, which allows mastitis to be considered a subgroup of the umbrella term of ICLB.
The variability regarding diagnosis (whether systemic symptoms and the number of symptoms are required), could again be due to variations in the mother’s presenting symptoms. Additionally, other diagnostic criteria such as the mother’s rating of severity of symptoms or functional impact  associated with ICLB may need to be considered as part of the diagnosis of ICLB. When considering what symptoms physiotherapists used for diagnosis, there was greater consistency surrounding the diagnosis of mastitis, compared to abscess, blocked ducts, engorgement (Table 5). Symptoms named in the ABM definition  of mastitis were the most commonly used by physiotherapists to diagnose mastitis. Previously published guidelines do not explicitly state symptoms associated with engorgement  and a published guideline that states symptoms associated with clinical diagnosis in abscess, blocked ducts, and engorgement for health care practitioners is needed.
Physiotherapists have traditionally used cardinal signs and symptoms of inflammation (heat, redness, swelling, pain, loss of function)  to diagnose ICLB, and this is likely to influence intervention choices. Nearly all physiotherapists in this study used the cardinal symptoms of inflammation  to diagnose mastitis (Table 5), but not for abscess, blocked ducts or engorgement. Physiotherapists did not necessarily consider these conditions to be an ICLB (Tables 4 and 5), and the word ‘inflammatory’ within the label ICLB may need to be reviewed. Alternatively, the pathophysiology for abscess, blocked ducts and engorgement may need to be more evident, to support their inclusion under the ICLB label.
The identified variability amongst physiotherapists’ definition and diagnosis of ICLB was not associated with the geographic region or type of work facility. These results are contrary to the findings of a recent audit  that showed regional and facility differences in choice of intervention and parameters used in the treatment of mastitis. The current study indicates that these regional and facility differences may not be explained by the physiotherapist’s underlying definition or diagnostic criteria for mastitis and other factors need to be considered. The previous audit  examined what physiotherapists recorded in case notes, but the current study directly questioned physiotherapists, which may account for differences between studies. The only finding that indicated a difference in regions for definition or diagnosis, was that physiotherapists’ from the state of Victoria were more likely to include blocked ducts in their definition of ICLB. The reason for this is unclear, but may be related to post-natal education of breast care or clinical pathways that are specific to the medical management of blocked ducts in Victoria, compared to other states.
Physiotherapists need to be aware that not all of their clinical peers may view abscess, blocked ducts and engorgement as they do, and this has implications for intervention choices and communication when transferring patient care. Continuing education and future clinical guidelines would need to clarify ICLB definitions and diagnosis. Physiotherapists need to communicate clear concise information to their patients, to provide cohesive care. There is a need for an empirically defined overarching definition of ICLB, potentially achieved through a multidisciplinary, international Delphi expert panel . This could provide guidance to physiotherapists and may reflect the diverse symptoms that present to physiotherapists clinically.
Limitations of this study may include a response bias if physiotherapists responded with an “ideal” answer. While an online mode enhanced accessibility, individual interviews or focus groups could have rendered further information to investigate any differences between an ‘ideal’ versus the ‘clinically used’ definition of ICLB. This study surveyed only physiotherapists, and the viewpoints of other health care professionals have not been represented. Although generalisability of qualitative findings are limited, the robust sample size and strategic distribution of responses Australia-wide remains a strength of this study.
This study showed that physiotherapists have varied impressions of what constitutes an ICLB and its diagnostic criteria. Clinically, this highlights the need for physiotherapists to clearly articulate their definition and diagnosis of an ICLB to patients and colleagues, for example when transferring care, and to improve treatment continuity. This study also indicates that continuing education courses, and future clinical guidelines would need to clarify definitions and diagnosis of ICLB. Overall, this study should prompt physiotherapists, who treat ICLB, to engage in explicit communication when discussing an ICLB.
Availability of data and materials
The datasets generated and/or analysed during the current study are not publicly available due to individual compromise of privacy but are available from the corresponding author on reasonable request.
Academy of breastfeeding medicine
Australian physiotherapy association
Inflammatory conditions of the lactating breast
Amir LH. ABM clinical protocol #4: mastitis, revised march 2014. Breastfeed Med. 2014;9(5):239–43.
Amir LH, Trupin S, Kvist LJ. Diagnosis and treatment of mastitis in breastfeeding women. J Hum Lact. 2014;30(1):10–3.
LactaResearch Group. LactaPedia. In. Edited by Boss M, Hartmann P. Frauenfeld (CH): Family Larsson-Rosenquist Foundation; 2018. https://lactapedia.com. Accessed 27 Apr 2020.
Cullinane M, Amir LH, Donath SM, Garland SM, Tabrizi SN, Payne MS, et al. Determinants of mastitis in women in the CASTLE study: a cohort study. BMC Fam Pract. 2015;16:181.
Foxman B, D'Arcy H, Gillespie B, Bobo JK, Schwartz K. Lactation mastitis: occurrence and medical management among 946 breastfeeding women in the United States. Am J Epidemiol. 2002;155(2):103–14.
Khanal V, Scott J, Lee A, Binns C. Incidence of mastitis in the neonatal period in a traditional breastfeeding society: results of a cohort study. Breastfeed Med. 2015;10(10):481–7.
Zarshenas M, Zhao Y, Poorarian S, Binns CW, Scott JA. Incidence and risk factors of mastitis in shiraz, Iran: results of a cohort study. Breastfeed Med. 2017;12(5):290–6.
Kvist LJ. Re-examination of old truths: replication of a study to measure the incidence of lactational mastitis in breastfeeding women. Int Breastfeed J. 2013;8:2.
Odedina SO, Ajayi IO, Adeniji-Sofoluwe A, Morhason-Bello IO, Huo D, Olopade OI, et al. A longitudinal study of the prevalence and characteristics of breast disorders detected by clinical breast examination during pregnancy and six months postpartum in Ibadan, Southern Nigeria. Nigeria BMC Womens Health. 2018;18:152.
Aktimur R, Kıymaz D, Gümüş K, Yıldırım K, Çetinkünar S, Özlem N. Experience and knowledge level of female health care professionals in Samsun province regarding puerperal mastitis. Ulus Cerrahi Derg. 2016;32(4):261–6.
Tang L, Lee AH, Qiu L, Binns CW. Mastitis in Chinese breastfeeding mothers: a prospective cohort study. Breastfeed Med. 2014;9(1):35–8.
Thompson JF, Roberts CL, Currie M, Ellwood DA. Prevalence and persistence of health problems after childbirth: associations with parity and method of birth. Birth. 2002;29(2):83–94.
Hoddinott P, Tappin D, Wright C. Breast feeding: a clinical review. BMJ. 2008;336(7649):881.
Cooke M, Schmied V, Sheehan A. An exploration of the relationship between postnatal distress and maternal role attainment, breast feeding problems and breast feeding cessation in Australia. Midwifery. 2007;23(1):66–76.
Mezzacappa E, Guethlein W, Katkin E. Breast-feeding and maternal health in online mothers. Ann Behav Med. 2002;24(4):299–309.
Lowe NK. The surgeon general's call to action to support breastfeeding. J Obstet Gynecol Neonatal Nurs. 2011;40(4):387–9.
Merriam-Webster. Mastitis. https://www.merriam-webster.com/dictionary/mastitis. Accessed 2 Nov 2018.
Online Etymology Dictionary. Mastitis. https://www.etymonline.com/word/mastitis. Accessed 2 Nov 2018.
Abou-Dakn M, Richardt A, Schaefer-Graf U, Wöckel A. Inflammatory breast diseases during lactation: milk stasis, puerperal mastitis, abscesses of the breast, and malignant tumors – current and evidence-based strategies for diagnosis and therapy. Breast Care. 2010;5(1):33–7.
Leong PW, Chotai NC, Kulkarni S. Imaging features of inflammatory breast disorders: a pictorial essay. Korean J Radiol. 2018;19(1):5–14.
Diepeveen LC, Fraser E, Croft AJE, Jacques A, McArdle AM, Briffa K, et al. Regional and facility differences in interventions for mastitis by Australian physiotherapists. J Hum Lact. 2019;35(4):695–705.
Kvist LJ. Care and treatment of women with inflammatory symptoms of the breast during lactation (doctoral thesis): Fakulteten för samhälls-och livsvetenskaper: Karlstad University; 2006.
O’Brien BC, Harris IB, Beckman TJ, Reed DA, Cook DA. Standards for reporting qualitative research: a synthesis of recommendations. Acad Med. 2014;89(9):1245–51.
Malterud K, Siersma VD, Guassora AD. Sample size in qualitative interview studies: guided by information power. Qual Health Res. 2016;26(13):1753–60.
Braun V, Clarke V. To saturate or not to saturate? Questioning data saturation as a useful concept for thematic analysis and sample-size rationales. Qual Res Sport, Exerc Health. 2019:1–16. https://doi.org/10.1080/2159676X.2019.1704846.
Fielding NG. Triangulation and mixed methods designs: data integration with new research technologies. J Mixed Methods Res. 2012;6(2):124–36.
Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101.
Sparkes AC, Smith B. Chapter 5: Qualitative Analysis. In: Sparkes AC, Smith B, editors. Qualitative Research Methods in Sport, Exercise and Health: From Process to Product. 1st ed. London, UK: Routledge; 2013. p. 115–46.
Hoddinott SN, Bass MJ. The dillman total design survey method. Can Fam Physician. 1986;32:2366–8.
Amir LH, Lumley J. Women's experience of lactational mastitis - I have never felt worse. Aust Fam Physician. 2006;35(9):745–7.
Berens P, Brodribb W. ABM clinical protocol #20: engorgement, revised 2016. Breastfeed Med. 2016;11(4):159–63.
Scott A, Khan KM, Cook JL, Duronio V. What is “inflammation”? Are we ready to move beyond Celsus? Br J Sports Med. 2004;38(3):248.
de Villiers M, de Villiers P, Kent A. The Delphi technique in health sciences education research. Med Teach. 2005;27(7):639–43.
The authors thank: Dr. Leo Ng for his guidance and feedback on the manuscript; and Natasa Tedman (NT) for her contribution to the project’s generation, data collection and initial data analysis.
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Ethics approval and consent to participate
The Human Research Ethics Committee approved this study (reference number HRE2018–0427). All participants provided informed consent by accessing the online link.
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Microsoft word document (.doc); Coding tree – the codes generated from the data/physiotherapist’s responses for use in the thematic analysis.
Microsoft word document (.doc); Coding manual – results of the thematic analysis including theme descriptions and examples.
About this article
Cite this article
Heron, E., Maselli, T., McArdle, A. et al. Exploring physiotherapists’ clinical definition and diagnosis of inflammatory conditions of the lactating breast in Australia: a mixed methods study. Int Breastfeed J 15, 48 (2020). https://doi.org/10.1186/s13006-020-00294-9
- Postpartum period